Sanofi-Aventis bets new plant on dengue vaccine success
This article was originally published in Scrip
Executive Summary
Sanofi-Aventis has committed €350 million to the construction of a manufacturing facility in France that it hopes will produce 100 million doses of a prophylactic dengue vaccine annually by 2013.